Conference call regarding Elekta's Interim Report for May-October 2012/13
STOCKHOLM -- November 14, 2012
Elekta (STO:EKTAB) will publish its interim report for May-October 2012/13 on
December 4 as per:
*The report will be published at 07.30 CET.
*Elekta will host a telephone conference at 10.00-11.00 CET with Tomas
Puusepp, President and CEO, and Håkan Bergström, CFO.
To take part in the conference call, please dial in about five minutes in
advance, use the telephone numbers below and the access code 925300
*UK dial-in number: +44 (0)20 7162 0077
*US dial-in number: + 1877491 0064
*Swedish dial-in number: +46 (0)85052 0110
The telephone conference will be broadcasted live online (audio only and
without the possibility to ask questions). Please use the link:
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow
enhancing software systems across the spectrum of cancer care. Stretching the
boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both healthcare
providers and patients, Elekta aims to improve, prolong and even save patient
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,400 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.
This information was brought to you by Cision http://www.cisionwire.com
Johan Andersson Melbi, Director Investor Relations,
Tel: +46702100 451,
Press spacebar to pause and continue. Press esc to stop.